TY - JOUR
T1 - An update
T2 - Cancer-associated anorexia as a treatment target
AU - Jatoi, Aminah
AU - Loprinzi, Charles L.
PY - 2001/5/1
Y1 - 2001/5/1
N2 - Loss of appetite is pervasive among patients with advanced cancer. Cancer patients cite it as one of their most troubling symptoms. To date, however, palliative options remain limited. Megestrol acetate and dexamethasone provide only modest relief. Novel agents such as thalidomide, adenosine triphosphate, and other cytokine inhibitors merit further investigation.
AB - Loss of appetite is pervasive among patients with advanced cancer. Cancer patients cite it as one of their most troubling symptoms. To date, however, palliative options remain limited. Megestrol acetate and dexamethasone provide only modest relief. Novel agents such as thalidomide, adenosine triphosphate, and other cytokine inhibitors merit further investigation.
UR - http://www.scopus.com/inward/record.url?scp=0035351249&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0035351249&partnerID=8YFLogxK
U2 - 10.1097/00075197-200105000-00002
DO - 10.1097/00075197-200105000-00002
M3 - Review article
C2 - 11517349
AN - SCOPUS:0035351249
SN - 1363-1950
VL - 4
SP - 179
EP - 182
JO - Current opinion in clinical nutrition and metabolic care
JF - Current opinion in clinical nutrition and metabolic care
IS - 3
ER -